Yu Zhao

7.7k total citations · 1 hit paper
172 papers, 6.1k citations indexed

About

Yu Zhao is a scholar working on Molecular Biology, Biomedical Engineering and Organic Chemistry. According to data from OpenAlex, Yu Zhao has authored 172 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Molecular Biology, 38 papers in Biomedical Engineering and 24 papers in Organic Chemistry. Recurrent topics in Yu Zhao's work include Nanoplatforms for cancer theranostics (27 papers), RNA Interference and Gene Delivery (24 papers) and Advanced biosensing and bioanalysis techniques (14 papers). Yu Zhao is often cited by papers focused on Nanoplatforms for cancer theranostics (27 papers), RNA Interference and Gene Delivery (24 papers) and Advanced biosensing and bioanalysis techniques (14 papers). Yu Zhao collaborates with scholars based in China, United States and Czechia. Yu Zhao's co-authors include Xinge Zhang, Chaoxing Li, Yang Liu, Xiaomei Dai, Zhanzhan Zhang, Yunjian Yu, Xiaosong Wei, Xuelei Chen, Qianqian Guo and Linqi Shi and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Yu Zhao

164 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advanced bioactive nanomaterials for biomedical applications

2021 274 citations Yu Zhao, Zhanzhan Zhang et al. profile →

Peers

Countries citing papers authored by Yu Zhao

Since Specialization

Citations

This map shows the geographic impact of Yu Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Zhao more than expected).

Fields of papers citing papers by Yu Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Zhao. The network helps show where Yu Zhao may publish in the future.

Co-authorship network of co-authors of Yu Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Zhao. A scholar is included among the top collaborators of Yu Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Zhao. Yu Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Strategies and applications of antibacterial surface-modified biomaterials 2025 ·Bioactive Materials ·(unknown), (unknown), Chuyao Wang, Qirong Zhou, Yu Zhao, Jiacan Su, Bao‐Ku Zhu	5
2	ALDH1A3 Regulates Cellular Senescence and Senescence-Associated Secretome in Prostate Cancer 2025 ·Cancers ·Sen Wang, Lin Wang, Yu Zhao	2
3	Rational design of lipid nanoparticles: overcoming physiological barriers for selective intracellular mRNA delivery 2024 ·Current Opinion in Chemical Biology ·Yu Zhao, (unknown), Donghui Song, Mengting Chen, Qiaobing Xu	7
4	Azobenzene-based liposomes with nanomechanical action for cytosolic chemotherapeutic drug delivery 2024 ·Colloids and Surfaces B Biointerfaces ·Cuicui Zhao, Shiyu Peng, (unknown), Xiaoxue Hou, Yu Zhao, Fan Huang	3
5	Cationic polymer coating that rapidly inactivates bacteria and resists bacterial adhesion 2024 ·Journal of Polymer Science ·Zihao Zhao, (unknown), Chuyao Wang, (unknown), Yu Zhao, Li‐Feng Fang, Bao‐Ku Zhu	3
6	Rational Design of Lipid-Based Vectors for Advanced Therapeutic Vaccines 2024 ·Vaccines ·Yufei Ma, Yiang Chen, Zilu Li, Yu Zhao	0
7	Harnessing Nanochaperone‐Mediated Autophagy for Selective Clearance of Pathogenic Tau Protein in Alzheimer's Disease 2024 ·Advanced Materials ·Linlin Xu, Xiaohui Wu, Shuyue Zhao, Haodong Hu, Silei Wang, Yongxin Zhang, Jiajing Chen, Xiaochen Zhang, Yu Zhao, Rujiang Ma, Fan Huang, Linqi Shi	10
8	Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m⁶A modification 2023 ·Theranostics ·Yu Zhao, Simeng Wen, Hang Li, (unknown), Yulei Wei, Ting Huang, (unknown), Yinhui Yang, Saijun Fan, Yingyi Zhang	24
9	Tailoring a Nanochaperone to Regulate α‐Synuclein Assembly 2022 ·Angewandte Chemie ·Xiaohui Wu, Feihe Ma, Binbin Pan, Yanli Zhang, Lin Zhu, Fēi Dèng, Linlin Xu, Yu Zhao, (unknown), Haihong Niu, Xun‐Cheng Su, Linqi Shi	1
10	“Spear and shield in one” nanochaperone enables protein to navigate multiple biological barriers for enhanced tumor synergistic therapy 2022 ·Biomaterials Science ·Xiaoxiao Zhang, Da‐Yuan Wang, Xiaohui Wu, Yu Zhao, Xue Li, Rujiang Ma, Fan Huang, Linqi Shi	5
11	Influence of cationic groups on the antibacterial behavior of cationic nano-sized hyperbranched polymers to enhance bacteria-infected wound healing 2022 ·Nanoscale ·(unknown), Zihao Zhao, Yu Zhao, Chuyao Wang, (unknown), Ze‐Lin Qiu, (unknown), (unknown), Li‐Feng Fang, Zhi Chen, Haihong Zhu, Bao‐Ku Zhu	13
12	Secondary Ammonium-Based Hyperbranched Poly(amidoamine) with Excellent Membrane-Active Property for Multidrug-Resistant Bacterial Infection 2022 ·ACS Applied Bio Materials ·(unknown), Ze‐Lin Qiu, Zihao Zhao, Chuyao Wang, (unknown), (unknown), Yu Zhao, (unknown), Li‐Feng Fang, Zhi Chen, Haihong Zhu, Bao‐Ku Zhu	0
13	Tailoring a Nanochaperone to Regulate α‐Synuclein Assembly 2022 ·Angewandte Chemie International Edition ·Xiaohui Wu, Feihe Ma, Binbin Pan, Yanli Zhang, Lin Zhu, Fēi Dèng, Linlin Xu, Yu Zhao, (unknown), Haihong Niu, Xun‐Cheng Su, Linqi Shi	16
14	An Antibody-like Polymeric Nanoparticle Removes Intratumoral Galectin-1 to Enhance Antitumor T-Cell Responses in Cancer Immunotherapy 2021 ·ACS Applied Materials & Interfaces ·Yu Gu, Yu Zhao, Zhanzhan Zhang, Jialei Hao, Yadan Zheng, Qi Liu, Yang Liu, Linqi Shi	19
15	Multifunctional Nanomodulators Regulate Multiple Pathways To Enhance Antitumor Immunity 2020 ·ACS Applied Bio Materials ·Yadan Zheng, Zhanzhan Zhang, Qi Liu, Yu Zhao, Chunxiong Zheng, Jialei Hao, Kaikai Yi, Ying Wang, Chun Wang, Xinzhi Zhao, Linqi Shi, Chunsheng Kang, Yang Liu	19
16	EZH 2 cooperates with gain‐of‐function p53 mutants to promote cancer growth and metastasis 2019 ·The EMBO Journal ·Yu Zhao, Liya Ding, Dejie Wang, Zhenqing Ye, Yundong He, Linlin Ma, Runzhi Zhu, Yunqian Pan, Qiang Wu, Kun Pang, Xiaonan Hou, Saravut J. Weroha, (unknown), Roger Coleman, Ilsa M. Coleman, R. Jeffery Karnes, Jun Zhang, Peter S. Nelson, Liguo Wang, Haojie Huang	60
17	NanoRNP Overcomes Tumor Heterogeneity in Cancer Treatment 2019 ·Nano Letters ·Qi Liu, Jinquan Cai, Yadan Zheng, Yanli Tan, Yunfei Wang, Zhanzhan Zhang, Chunxiong Zheng, Yu Zhao, Chaoyong Liu, Yingli An, Chuanlu Jiang, Linqi Shi, Chunsheng Kang, Yang Liu	52
18	PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer 2017 ·Clinical Cancer Research ·Yinhui Yang, Yang Bai, Yundong He, Yu Zhao, Jiaxiang Chen, Linlin Ma, Yunqian Pan, Michael Hinten, Jun Zhang, R. Jeffrey Karnes, Manish Kohli, Jennifer J. Westendorf, Benyi Li, Runzhi Zhu, Haojie Huang, Wanhai Xu	50
19	Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade 2016 ·Cancer Research ·Yu Zhao, Hang Li, Yingyi Zhang, Leilei Li, Runping Fang, Yinghui Li, Qian Liu, Weiying Zhang, (unknown), Fabao Liu, Xiaodong Zhang, Lihong Ye	82
20	Synthesis and Antioxidant Properties of Novel Silybin Analogues 2006 ·Chinese Chemical Letters ·Jing‐Xu Gong, (unknown), Feng Wang, Yubin Feng, (unknown), Haibo Li, Yihang Wu, Xiao‐Jiang Hao, Xiumei Wu, Hua Bai, Joachim Stöckigt, Yu Zhao	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact